Ifp Advisors, Inc Chemo Centryx, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 06, 2021	SELL	$13.18 - $19.83 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$9.59 - $50.88 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$49.53 - $68.4 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$47.25 - $65.16 $378 - $521	-8 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$46.35 - $61.69 $370 - $493	8 New	8 $0

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.